It's crunch time for biotech projects started on a bet that the industry would shake off its multiyear malaise.

Investorideas , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Life Sciences and AI sectors ...

A House committee will hold a hearing this week scrutinizing whether National Institutes of Health animal research amounts to ...

Kier considers all Lumon employees his “children.” But if you’re a Severance fan, it’s best to know his actual children, too.

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

The Penn Center for Innovation has enabled world-changing advancements, from mRNA vaccines to CAR T cancer treatments.

My patients have shared with me a newfound mistrust over the safety of all vaccines since the Covid vaccine mandates were forced upon them,” writes a rural public health officer.

BOSTON, MASSACHUSETTS, Jan. 22, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing ... the spike proteins of viruses such as ...

BIO’s view: “Preserving U.S. leadership in biotechnology is imperative for economic ... biotech breakthroughs that will allow us to win the 21st century biotech race.” Join us June 16-19, 2025, in ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

Pharmaceutical Market Size and Growth 2025 to 2034The global pharmaceutical market size was valued at USD 1,607.07 billion in ...